Citations

Mayo Clinic

Showing 10 of 108602 citations.

450 Serum 25-hydroxyvitamin d3 levels and flares of systemic lupus erythematosus: a longitudinal cohort analysis
Mok, CC, Jannetto, Paul J. , Singh, Ritu

Poster Session | July 17, 2017 | Volume: No volume available | Issue: No issue available | Pages: A216.1-A216

10.1136/lupus-2017-000215.450 Get It

10 Single cell expression quantitative trait LOCI (EQTL) analsis of established lupus-risk loci in patient monocytes
Ghodke-Puranik, Y, Zhongbo, J, Fan, W, Dorschner, J.M., Vsetecka, Danielle, Amin, Shreyasee , Ernste, Floranne C. , Osborn, Thomas G. , Moder, Kevin G., Chowdhary, Vaidehi , Ghodke‐Puranik, Yogita , Fan, W, Jensen, M, Makol, Ashima , Niewold, Timothy B.

Plenary Session 4: Cutting edge science in SLE | July 17, 2017 | Volume: No volume available | Issue: No issue available | Pages: A6.2-A7

10.1136/lupus-2017-000215.10 Get It

Clinical limitations of the International Federation of Gynecology and Obstetrics (FIGO) classification of uterine fibroids
Laughlin-Tommaso, S.K., Hesley, Gina K. , Hopkins, Matthew R. , Brandt, Kathleen R. , Zhu, Yunxiao , Stewart, Elizabeth A.

International Journal of Gynecology & Obstetrics | July 17, 2017 | Volume: 139 | Issue: 2 | Pages: 143-148

10.1002/ijgo.12266 | PMID 28715088 Get It

AbstractObjectiveTo determine the reproducibility of classifying uterine fibroids using the 2011 International Federation of Gynecology and Obstetrics (FIGO) staging system.MethodsThe present retrospective cohort study included patients presenting for the treatment of symptomatic uterine fibroids at the Gynecology Fibroid Clinic at Mayo Clinic, Rochester, USA, between April 1, 2013 and April 1, 2014. Magnetic resonance imaging of fibroid uteri was performed and the images were independently reviewed by two academic gynecologists and two radiologists specializing in fibroid care. Fibroid classifications assigned by each physician were compared and the significance of the variations was graded by whether they would affect surgical planning.ResultsThere were 42 fibroids from 23 patients; only 6 (14%) fibroids had unanimous classification agreement. The majority (36 [86%]) had at least two unique answers and 4 (10%) fibroids had four unique classifications. Variations in classification were not associated with physician specialty. More than one‐third of the classification discrepancies would have impacted surgical planning.ConclusionFIGO fibroid classification was not consistent among four fibroid specialists. The variation was clinically significant for 36% of the fibroids. Additional validation of the FIGO fibroid classification system is needed.
Perceptions of the Donation Process from Adult-to-Adult Living Liver Donors
Winsett, Rebecca P., Russell, Cynthia K. , Grewal, Hani P., Shokouh-Amiri, Hosein M. , Gaber, A. Osama

Progress in Transplantation | July 17, 2017 | Volume: 13 | Issue: 2 | Pages: 123-129

10.1177/152692480301300209 | PMID 12841519 Get It

Background Donor safety and the impact on quality of life continue to concern transplant centers as living liver transplantation increases. Methods Living liver donors participated in a focus group to discuss their perceptions of the donation process. Results The decision to donate was a personal choice made before the request by the recipient or transplant service. Spouses verified their support, but indicated that they were not included in the process. No donors felt coerced. The explanation of the procedure was thorough but excessive. Hospital care was good; however, donors admitted being unprepared for the pain and side effects of pain medications. Ongoing incisional discomfort continued beyond 6 weeks and prevented donors from feeling normal. Donors felt conflicted about competing with the “true” patient for healthcare. Conclusions Donors were positive about the need and willingness to donate. Sensitivity to the order of the disclosure process is identified.
BK Virus in Kidney Transplantation: A Case Study
Boyum, Denise A.

Progress in Transplantation | July 17, 2017 | Volume: 14 | Issue: 3 | Pages: 176-180

10.1177/152692480401400302 | PMID 15495776 Get It

Prevention as well as treatment of viral infections in transplant recipients relies on minimal immunosuppressive therapy consistent with graft survival and the use of antiviral therapies in proportion to perceived risk. BK virus creates an even greater challenge in posttransplant management and graft survival because of difficulty in diagnosing and treatment. BK nephropathy develops in 1% to 5% of transplant recipients, with loss of allograft function occurring in 50% of the cases. We present a case of a 67-year-old man who developed BK virus allograft nephropathy 9.5 months after transplantation. His allograft function was extended through rigorous treatment with an antiviral agent, reduction of immunosuppressant, and monitoring in an outpatient setting.
A Multiethnic Study of the Relationship between Fears and Concerns and Refusal Rates
Verble, Margaret, Bowen, Gordon, Kay, Nancy, Mitoff, Jeffrey, Shafer, Teresa , Worth, Judy, Kay, Nancy

Progress in Transplantation | July 17, 2017 | Volume: 12 | Issue: 3 | Pages: 185-190

10.1177/152692480201200306 | PMID 12371044 Get It

This study builds on previous research that identified fears and concerns heard by procurement coordinators during the donation discussion and that classified those concerns according to the ease with which they can be addressed. In this study, 53 coordinators working for 4 procurement agencies provided data on 323 donation discussions, including fears and concerns expressed by families. The fears and concerns were analyzed by outcome (consent or refusal), race and ethnicity of the family, frequency of reports, and difficulty in addressing. This research confirms many of the findings of the earlier study. The results also indicate that the types of concerns expressed by donor and non–donor families vary somewhat by the family's race and ethnicity. The results can be used to provide training targeted at raising consent rates and to train minority requestors.
Impact of Long-Term Immunosuppressive Therapy on Psychosocial and Physical Well Being in Liver Transplant Recipients
Kizilisik, A.T, Grewal, Hani P., Vera, Santiago, Hathaway, Donna, Shokouh-Amiri, Hosein M. , Gaber, A. Osama

Progress in Transplantation | July 17, 2017 | Volume: 13 | Issue: 4 | Pages: 278-283

10.1177/152692480301300407 | PMID 14765720 Get It

To achieve the fullest potential of transplantation, continuing concern for the recipients' quality of life must be a part of the process. Database records of patients who are currently alive and received transplants between 1982 and 1991 were retrospectively analyzed. Recipients were contacted and asked to answer a quality-of-life questionnaire. Of 105 liver transplant recipients, 51 died within 10 years after transplantation; 47 were contacted. Posttransplant complications included hypertension (64%), posttransplant diabetes mellitus (17%), osteopenia (40%), osteoporosis (26%), and heart disease (17%). Most recipients reported all aspects of their life to be average, if not better than their age-matched peers. Although most recipients complained about side effects of immunosuppressive agents, they were all happy to be alive and agreed that their quality of life showed an impressive favorable change to a level exceeding that of the general population. These results suggest that liver transplantation not only improved survival but also quality of life.
Bridge to Decision: SWAT Team Approach Used by Mayo Clinic Arizona's Cardiac Transport Team
Staley, Linda L., Dobberpuhl, Jeff, Pierce, Christopher N., Scott, Robert L. , Jaroszewski, Dawn E. , Arabía, Francisco A.

Progress in Transplantation | July 17, 2017 | Volume: 20 | Issue: 2 | Pages: 118-124

10.1177/152692481002000204 | PMID 20642168 Get It

Objective Patients in acute cardiogenic shock are the most challenging patients to manage. Unless a mechanical circulatory assist device is placed, maintaining end-organ function can be difficult. Transporting cardiogenic shock patients to tertiary care centers for higher level care also is difficult. The Mayo Clinic Arizona uses a SWAT team approach to deploy a specialized medical or surgical multidisciplinary team to implant mechanical circulatory assist devices at referring hospitals and transport patients back to Mayo Clinic Arizona. Results The cardiac transport team at Mayo Clinic Arizona got 23 referrals from 15 local community hospitals from February 2006 to September 2009. The medical team deployed for transfers of 6 patients, 3 of whom survived to hospital discharge. The surgical transport team deployed for transfers of 17 patients (6 with left ventricular assist devices, 2 with right ventricular assist devices, 5 with biventricular assist devices, and 4 with extracorporeal membrane oxygenation), of whom 8 survived to hospital discharge. Ten of the 17 referrals (59%) required a surgeon to place a mechanical circulatory assist device at the referring hospital. Conclusion The SWAT team approach allows cardiogenic shock patients to be stabilized at the referring hospital by heart failure and cardiac surgical specialists. If necessary, a surgeon from Mayo Clinic Arizona places a mechanical circulatory assist device at the referring hospital to stabilize the patient. Doing so allows safe transport back to the tertiary care center for higher level care and possible transplant evaluation with placement of a long-term durable device.
Recommendations for the clinical management of patients receiving macitentan for pulmonary arterial hypertension (PAH): A Delphi consensus document
Rahaghi, Franck , Alnuaimat, Hassan, Awdish, Rana , Balasubramanian, Vijay , Bourge, Robert C. , Butler, John, Cauthen, C. Gregory, Chakinala, Murali M. , deBoisblanc, Bennett P., Eggert, Michael, Engel, Peter A., Feldman, Jeremy, McConnell, J.W. , Park, Myung, Sager, Jeffrey S., Sood, Namita , Palevsky, Harold I. , Burger, Charles D.

Pulmonary Circulation | July 17, 2017 | Volume: 7 | Issue: 3 | Pages: 702-711

10.1177/2045893217721695 | PMID 28671484 Get It

In patients treated with macitentan (Opsumit®, Actelion Pharmaceuticals Ltd., Basel, Switzerland) for pulmonary arterial hypertension (PAH), prevention and/or effective management of treatment‐related adverse events may improve adherence. However, management of these adverse events can be challenging and the base of evidence and clinical experience for macitentan is limited. In the absence of evidence, consensus recommendations from physicians experienced in using macitentan to treat PAH may benefit patients and physicians who are using macitentan. Consensus recommendations were developed by a panel of physicians experienced with macitentan and PAH using a modified Delphi process. Over three iterations, panelists developed and refined a series of statements on the use of macitentan in PAH and rated their agreement with each statement on a Likert scale. The panel of 18 physicians participated and developed a total of 118 statements on special populations, add‐on therapy, drug–drug interactions, warnings and precautions, hospitalization and functional class, and adverse event management. The resulting consensus recommendations are intended to provide practical guidance on real‐world issues in using macitentan to treat patients with PAH.
Effect of Klebsiella ozaenae on ciliary activity in vitro: Implications in the pathogenesis of atrophic rhinitis
Ferguson, Jonathan L., McCaffrey, Thomas V., Kern, Eugene B. , Martin, William J., Martin, William J.

Otolaryngology–Head and Neck Surgery | July 17, 2017 | Volume: 102 | Issue: 3 | Pages: 207-211

10.1177/019459989010200301 | PMID 2108406 Get It

Klebsiella ozaenae is a gram‐negative rod that has been isolated with relative frequency from patients with atrophic rhinitis. The relationship of this bacterium to the pathogenesis of atrophic rhinitis is not understood, and whether this bacterium is simply an opportunistic colonizer of the injured nose or the etiologic agent of the disease is unclear. This study was designed to investigate a potential role for bacterially produced cilloinhibition as a mechanism for the pathogenesis of atrophic rhinitis.